A detailed history of Geode Capital Management, LLC transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,728,285 shares of ENOB stock, worth $7.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,728,285
Previous 437,968 294.61%
Holding current value
$7.95 Million
Previous $2.01 Million 294.74%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
N/A
1,290,317 Added 294.61%
1,728,285 $7.95 Million
Q1 2024

May 13, 2024

BUY
N/A
75,559 Added 20.85%
437,968 $2.01 Million
Q4 2023

Feb 13, 2024

BUY
$4.3 - $4.7 $255,054 - $278,780
59,315 Added 19.57%
362,409 $1.67 Million
Q3 2023

Nov 13, 2023

BUY
$0.0 - $4.46 $0 - $656,659
147,233 Added 94.46%
303,094 $1.35 Million
Q2 2023

Aug 11, 2023

SELL
$0.4 - $1.3 $65,197 - $211,892
-162,994 Reduced 51.12%
155,861 $88,000
Q1 2023

May 15, 2023

BUY
$0.91 - $1.31 $65 - $94
72 Added 0.02%
318,855 $293,000
Q4 2022

Feb 13, 2023

BUY
$1.03 - $2.13 $127 - $264
124 Added 0.04%
318,783 $328,000
Q3 2022

Nov 14, 2022

SELL
$1.7 - $2.86 $598 - $1,006
-352 Reduced 0.11%
318,659 $576,000
Q2 2022

Aug 12, 2022

BUY
$1.93 - $8.73 $324,421 - $1.47 Million
168,094 Added 111.38%
319,011 $615,000
Q1 2022

May 13, 2022

SELL
$4.42 - $9.0 $9,582 - $19,512
-2,168 Reduced 1.42%
150,917 $1.25 Million
Q4 2021

Feb 11, 2022

SELL
$6.71 - $12.55 $365,580 - $683,761
-54,483 Reduced 26.25%
153,085 $1.12 Million
Q3 2021

Nov 12, 2021

BUY
$4.56 - $7.88 $271,361 - $468,930
59,509 Added 40.19%
207,568 $1.4 Million
Q2 2021

Aug 13, 2021

SELL
$2.94 - $6.79 $429,769 - $992,562
-146,180 Reduced 49.68%
148,059 $735,000
Q1 2021

May 12, 2021

BUY
$3.02 - $4.51 $30,819 - $46,024
10,205 Added 3.59%
294,239 $1.04 Million
Q4 2020

Feb 12, 2021

BUY
$2.82 - $3.55 $12,300 - $15,485
4,362 Added 1.56%
284,034 $837,000
Q3 2020

Nov 13, 2020

BUY
$3.42 - $4.55 $30,273 - $40,276
8,852 Added 3.27%
279,672 $1 Million
Q2 2020

Aug 13, 2020

BUY
$2.78 - $6.06 $40,921 - $89,203
14,720 Added 5.75%
270,820 $1.14 Million
Q1 2020

May 14, 2020

BUY
$2.08 - $5.41 $79,173 - $205,926
38,064 Added 17.46%
256,100 $768,000
Q4 2019

Feb 13, 2020

BUY
$3.48 - $6.75 $564,490 - $1.09 Million
162,210 Added 290.56%
218,036 $1.09 Million
Q3 2019

Nov 12, 2019

BUY
$3.95 - $5.72 $9,112 - $13,196
2,307 Added 4.31%
55,826 $307,000
Q2 2019

Aug 14, 2019

BUY
$4.5 - $6.99 $240,835 - $374,097
53,519 New
53,519 $240,000

Others Institutions Holding ENOB

About Enochian Biosciences Inc


  • Ticker ENOB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,950,000
  • Market Cap $244M
  • Description
  • Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...
More about ENOB
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.